← Back to Search

Behavioural Intervention

Mental Health Support for Cancer

N/A

Recruiting

Led By Kelly McConnell, PhD

Research Sponsored by Memorial Sloan Kettering Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Per medical record, diagnosed with breast, colorectal, lung, or prostate cancer at age 65 years or older

Per self-report, provided cancer care for at least three years at time of consent

Must not have

N/A

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

No Placebo-Only Group

Summary

This trial looks at mental health services for older adults with cancer & depressed mood, comparing usual approaches with the OD-C approach to see if it's useful.

Who is the study for?

This trial is for adults over 65 with breast, colorectal, lung, or prostate cancer who are currently in treatment or have finished within the last six months. They must speak English well and show signs of depression. It's not for those severely cognitively impaired, too ill to participate, receiving hospice care, or already in mental health treatment.

What is being tested?

The study tests a new way called OD-C to help older adults with cancer and depressed mood get mental health services. It compares this approach with usual methods by using questionnaires, interviews and regular calls to see if it's helpful for patients and practical for providers.

What are the potential side effects?

Since this trial involves non-medical interventions like questionnaires and interviews rather than drugs or medical procedures, traditional side effects aren't expected. Participants may experience emotional discomfort discussing their mental health.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I was diagnosed with breast, colorectal, lung, or prostate cancer at 65 or older.

Select...

I have been receiving cancer treatment for at least three years.

Select...

You are a patient.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Attrition rates

Refusal rates

Secondary study objectives

Treatment satisfaction

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Open Door for Cancer (OD-C)Experimental Treatment1 Intervention

OD-C includes five components delivered in three 30-minute telephone or videoconference visits over six weeks and one booster telephone call. All sessions are audio-recorded.

Group II: Usual CareActive Control2 Interventions

Participants assigned to Usual Care (n=50) will receive standard care. MSK's current usual care for distress screening is that all patients are screened for distress when they initiate care at MSK. Additional distress screening is conducted based on the determination of the oncology team. In addition, patients are referred to social work, psychology, and/or psychiatry based on the judgment of the oncology team.

0 / 4Eligibility criteria met